OBJECTIVE: We previously observed the association of the co-occurrence of the HLA-DRB1 shared epitope (SE) and RANKL single-nucleotide polymorphisms (SNPs) with younger age at the onset of rheumatoid arthritis (RA) in 182 rheumatoid factor (RF)-positive European American patients with early-onset RA. The aim of this study was to fine-map the 48-kb RANKL region in the extended cohort of 210 European American RF-positive patients with early RA, to seek replication of RA-associated SNPs in additional RA cohorts of 501 European Americans and 298 African Americans, and to explore the functional consequences of RA-associated SNPs. METHODS: SNP genotyping was conducted using pyrosequencing or TaqMan polymerase chain reaction (PCR) assays. Associations of rs7984870 with RANKL expression in plasma, peripheral blood mononuclear cells, and isolated T cells were quantified using enzyme-linked immunosorbent assay and reverse transcription-PCR. Site-directed mutagenesis of rs7984870 within the 2-kb RANKL promoter was performed to drive the luciferase reporter gene in osteoblast and stromal cell lines. Interaction of DNA and protein was determined by electrophoretic mobility shift assay. RESULTS: A single promoter SNP, rs7984870, was consistently significantly associated with earlier age at the onset of RA in 3 independent seropositive (RF or anti-cyclic citrullinated peptide antibody) RA cohorts but not in seronegative RA patients. The C risk allele of rs7984870 conferred 2-fold higher plasma RANKL levels in RF-positive patients with RA, significantly elevated RANKL messenger RNA expression in activated normal T cells, and increased promoter activity after stimulation in vitro via differential binding to the transcription factor SOX5. CONCLUSION: The RANKL promoter allele that increased transcription levels upon stimulation might promote interaction between activated T cells and dendritic cells, predisposing to a younger age at the onset of RA in seropositive European American and African American patients.
OBJECTIVE: We previously observed the association of the co-occurrence of the HLA-DRB1 shared epitope (SE) and RANKL single-nucleotide polymorphisms (SNPs) with younger age at the onset of rheumatoid arthritis (RA) in 182 rheumatoid factor (RF)-positive European American patients with early-onset RA. The aim of this study was to fine-map the 48-kb RANKL region in the extended cohort of 210 European American RF-positive patients with early RA, to seek replication of RA-associated SNPs in additional RA cohorts of 501 European Americans and 298 African Americans, and to explore the functional consequences of RA-associated SNPs. METHODS: SNP genotyping was conducted using pyrosequencing or TaqMan polymerase chain reaction (PCR) assays. Associations of rs7984870 with RANKL expression in plasma, peripheral blood mononuclear cells, and isolated T cells were quantified using enzyme-linked immunosorbent assay and reverse transcription-PCR. Site-directed mutagenesis of rs7984870 within the 2-kb RANKL promoter was performed to drive the luciferase reporter gene in osteoblast and stromal cell lines. Interaction of DNA and protein was determined by electrophoretic mobility shift assay. RESULTS: A single promoter SNP, rs7984870, was consistently significantly associated with earlier age at the onset of RA in 3 independent seropositive (RF or anti-cyclic citrullinated peptide antibody) RA cohorts but not in seronegative RApatients. The C risk allele of rs7984870 conferred 2-fold higher plasma RANKL levels in RF-positive patients with RA, significantly elevated RANKL messenger RNA expression in activated normal T cells, and increased promoter activity after stimulation in vitro via differential binding to the transcription factor SOX5. CONCLUSION: The RANKL promoter allele that increased transcription levels upon stimulation might promote interaction between activated T cells and dendritic cells, predisposing to a younger age at the onset of RA in seropositive European American and African American patients.
Authors: Gaetano Zafarana; Ad J M Gillis; Ruud J H L M van Gurp; Per G Olsson; Fons Elstrodt; Hans Stoop; José Luis Millán; J Wolter Oosterhuis; Leendert H J Looijenga Journal: Cancer Res Date: 2002-03-15 Impact factor: 12.701
Authors: Y Y Kong; U Feige; I Sarosi; B Bolon; A Tafuri; S Morony; C Capparelli; J Li; R Elliott; S McCabe; T Wong; G Campagnuolo; E Moran; E R Bogoch; G Van; L T Nguyen; P S Ohashi; D L Lacey; E Fish; W J Boyle; J M Penninger Journal: Nature Date: 1999-11-18 Impact factor: 49.962
Authors: F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra Journal: Arthritis Rheum Date: 1988-03
Authors: S L Bridges; L B Hughes; T R Mikuls; G Howard; H K Tiwari; G S Alarcón; J M McNicholl; L W Moreland Journal: Clin Exp Rheumatol Date: 2003 Sep-Oct Impact factor: 4.473
Authors: Jennifer L Roccisana; Noriaki Kawanabe; Hiroshi Kajiya; Masanori Koide; G David Roodman; Sakamuri V Reddy Journal: J Biol Chem Date: 2003-12-29 Impact factor: 5.157
Authors: Stephen Eyre; Anne Hinks; Edward Flynn; Paul Martin; Anthony G Wilson; James R Maxwell; Ann W Morgan; Paul Emery; Sophia Steer; Lynne J Hocking; David M Reid; Pille Harrison; Paul Wordsworth; Wendy Thomson; Jane Worthington; Anne Barton Journal: Ann Rheum Dis Date: 2009-11-27 Impact factor: 19.103
Authors: Laura A McIntosh; Miranda C Marion; Marc Sudman; Mary E Comeau; Mara L Becker; John F Bohnsack; Tasha E Fingerlin; Thomas A Griffin; J Peter Haas; Daniel J Lovell; Lisa A Maier; Peter A Nigrovic; Sampath Prahalad; Marilynn Punaro; Carlos D Rosé; Carol A Wallace; Carol A Wise; Halima Moncrieffe; Timothy D Howard; Carl D Langefeld; Susan D Thompson Journal: Arthritis Rheumatol Date: 2017-10-12 Impact factor: 10.995
Authors: Mark N Cruickshank; Mahdad Karimi; Rhonda L Mason; Emily Fenwick; Tim Mercer; Betty P Tsao; Susan A Boackle; Daniela Ulgiati Journal: Mol Immunol Date: 2012-06-04 Impact factor: 4.407
Authors: Vincent A Laufer; Hemant K Tiwari; Richard J Reynolds; Maria I Danila; Jelai Wang; Jeffrey C Edberg; Robert P Kimberly; Leah C Kottyan; John B Harley; Ted R Mikuls; Peter K Gregersen; Devin M Absher; Carl D Langefeld; Donna K Arnett; S Louis Bridges Journal: Hum Mol Genet Date: 2019-03-01 Impact factor: 6.150
Authors: Ian C Scott; Seth D Seegobin; Sophia Steer; Rachael Tan; Paola Forabosco; Anne Hinks; Stephen Eyre; Ann W Morgan; Anthony G Wilson; Lynne J Hocking; Paul Wordsworth; Anne Barton; Jane Worthington; Andrew P Cope; Cathryn M Lewis Journal: PLoS Genet Date: 2013-09-19 Impact factor: 5.917
Authors: Daisuke Sakurai; Jian Zhao; Yun Deng; Jennifer A Kelly; Elizabeth E Brown; John B Harley; Sang-Cheol Bae; Marta E Alarcόn-Riquelme; Jeffrey C Edberg; Robert P Kimberly; Rosalind Ramsey-Goldman; Michelle A Petri; John D Reveille; Luis M Vilá; Graciela S Alarcón; Kenneth M Kaufman; Timothy J Vyse; Chaim O Jacob; Patrick M Gaffney; Kathy Moser Sivils; Judith A James; Diane L Kamen; Gary S Gilkeson; Timothy B Niewold; Joan T Merrill; R Hal Scofield; Lindsey A Criswell; Anne M Stevens; Susan A Boackle; Jae-Hoon Kim; Jiyoung Choi; Bernardo A Pons-Estel; Barry I Freedman; Juan-Manuel Anaya; Javier Martin; C Yung Yu; Deh-Ming Chang; Yeong Wook Song; Carl D Langefeld; Weiling Chen; Jennifer M Grossman; Rita M Cantor; Bevra H Hahn; Betty P Tsao Journal: PLoS Genet Date: 2013-10-10 Impact factor: 5.917
Authors: Adeline Ruyssen-Witrand; Yannick Degboé; A Cantagrel; D Nigon; C Lukas; S Scaramuzzino; Y Allanore; O Vittecoq; T Schaeverbeke; J Morel; J Sibilia; A Cambon-Thomsen; P Dieudé; A Constantin Journal: RMD Open Date: 2016-09-08